{"studyId":"pcnsl_msk_2024","cancerTypeId":"pcnsl","name":"Primary CNS Lymphoma (MSK, Clin Cancer Res 2024)","description":"Targeted sequencing of 86 samples from 44 patients with primary CNS lymphoma with their matched normals via HemePACT. A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma. A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma.","publicStudy":true,"pmid":"38995739","citation":"Grommes, Christian et al. Clin Cancer Res 2024","groups":"","status":1,"importDate":"2026-01-12 16:25:16","allSampleCount":86,"sequencedSampleCount":86,"cnaSampleCount":86,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":0,"cancerType":{"id":"pcnsl","name":"Primary DLBCL of the central nervous system","dedicatedColor":"LimeGreen","shortName":"PCNSL","parent":"mbn"},"readPermission":true,"resourceCounts":[]}